Research
Neural
GLP-1 agonists can modulate appetite through effects on the hypothalamus, making them promising for obesity treatment.
GLP-1 agonists may be effective options for patients looking to manage obesity through appetite control.
StrongSupportsmedium confidence
An important feature of GLP-1 drugs is their ability to modulate appetite through effect on the hypothalamus, which makes them promising for the treatment of obesity.
Why this rating
The claim is supported by research on the physiological effects of GLP-1.
Source
Therapeutic strategies, consequences and prospects of glucagon-like peptide-1 agonists
N.M. Bobok · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · 2025
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →